首页 > 最新文献

Journal of the Intensive Care Society最新文献

英文 中文
Gastric residual volume monitoring practices in UK intensive care units: A web-based survey 英国重症监护病房的胃残余容积监测实践:网络调查
IF 2.7 Q3 CRITICAL CARE MEDICINE Pub Date : 2023-11-20 DOI: 10.1177/17511437231210483
B. Jenkins, Philip C Calder, Luise V Marino
Monitoring of gastric residual volume (GRV) to assess for enteral feeding intolerance is common practice in the intensive care unit (ICU) setting; however, evidence to support the practice is lacking. The aim of this study was: (i) to gain a perspective of current practice in adult ICUs in the UK around enteral feeding and monitoring of GRV, (ii) to characterise the threshold value used for a high GRV in clinical practice, (iii) to describe the impact of GRV monitoring on enteral feeding provision and (iv) to inform future research into the clinical value of GRV measurement in the adult ICU population. A web-based survey was sent to all UK adult ICUs. The survey consisted of questions pertaining to (i) nutritional assessment and enteral feeding practices, (ii) enteral feeding intolerance and GRV monitoring and (iii) management of raised GRV. Responses were received from 101 units. Ninety-eight percent of units reported routinely measuring GRV, with 86% of ICUs using GRV to define enteral feeding intolerance. Threshold values for a high GRV varied from 200 to 1000 ml with frequency of measurement also differing greatly from 2 to 12 hourly. Initiation of pro-kinetic medication was the most common treatment for a high GRV. Fifty-two percent of respondents stated that volume of GRV would influence their decision to stop enteral feeds a lot or very much. Only 28% of units stated that they had guidelines for the technique for monitoring GRV. Measurement of GRV is the most common method of determining enteral feeding intolerance in adult ICUs in the UK. The practice continues despite evidence of poor validity and reproducibility of this measurement. Further research should be undertaken into the benefit of ongoing GRV measurements in the adult ICU population and alternative markers of enteral feeding intolerance.
监测胃剩余容积(GRV)以评估肠道喂养不耐受性是重症监护病房(ICU)的常见做法,但缺乏支持该做法的证据。本研究的目的是:(i) 了解英国成人 ICU 目前在肠内喂养和监测 GRV 方面的做法,(ii) 描述临床实践中使用的高 GRV 临界值,(iii) 描述 GRV 监测对肠内喂养供应的影响,(iv) 为今后研究 GRV 测量在成人 ICU 群体中的临床价值提供信息。我们向英国所有成人重症监护病房发送了一份网络调查问卷。调查内容包括与以下方面相关的问题:(i) 营养评估和肠内喂养实践;(ii) 肠内喂养不耐受和 GRV 监测;(iii) GRV 升高的管理。共收到 101 个单位的回复。98%的重症监护室报告称已对 GRV 进行常规测量,其中 86% 的重症监护室使用 GRV 来定义肠内喂养不耐受。GRV 高的阈值从 200 毫升到 1000 毫升不等,测量频率也有很大差异,从每小时 2 次到 12 次不等。开始使用促动力药物是治疗高GRV最常见的方法。52% 的受访者表示,GRV 容量对他们决定是否停止肠内喂养有很大或非常大的影响。只有 28% 的医疗单位表示他们有监测 GRV 的技术指南。测量 GRV 是英国成人重症监护病房确定肠内喂养不耐受的最常用方法。尽管有证据表明这种测量方法的有效性和可重复性较差,但这种做法仍在继续。应进一步研究在成人 ICU 群体中持续测量 GRV 的益处以及肠内喂养不耐受的替代标记物。
{"title":"Gastric residual volume monitoring practices in UK intensive care units: A web-based survey","authors":"B. Jenkins, Philip C Calder, Luise V Marino","doi":"10.1177/17511437231210483","DOIUrl":"https://doi.org/10.1177/17511437231210483","url":null,"abstract":"Monitoring of gastric residual volume (GRV) to assess for enteral feeding intolerance is common practice in the intensive care unit (ICU) setting; however, evidence to support the practice is lacking. The aim of this study was: (i) to gain a perspective of current practice in adult ICUs in the UK around enteral feeding and monitoring of GRV, (ii) to characterise the threshold value used for a high GRV in clinical practice, (iii) to describe the impact of GRV monitoring on enteral feeding provision and (iv) to inform future research into the clinical value of GRV measurement in the adult ICU population. A web-based survey was sent to all UK adult ICUs. The survey consisted of questions pertaining to (i) nutritional assessment and enteral feeding practices, (ii) enteral feeding intolerance and GRV monitoring and (iii) management of raised GRV. Responses were received from 101 units. Ninety-eight percent of units reported routinely measuring GRV, with 86% of ICUs using GRV to define enteral feeding intolerance. Threshold values for a high GRV varied from 200 to 1000 ml with frequency of measurement also differing greatly from 2 to 12 hourly. Initiation of pro-kinetic medication was the most common treatment for a high GRV. Fifty-two percent of respondents stated that volume of GRV would influence their decision to stop enteral feeds a lot or very much. Only 28% of units stated that they had guidelines for the technique for monitoring GRV. Measurement of GRV is the most common method of determining enteral feeding intolerance in adult ICUs in the UK. The practice continues despite evidence of poor validity and reproducibility of this measurement. Further research should be undertaken into the benefit of ongoing GRV measurements in the adult ICU population and alternative markers of enteral feeding intolerance.","PeriodicalId":39161,"journal":{"name":"Journal of the Intensive Care Society","volume":"291 10","pages":""},"PeriodicalIF":2.7,"publicationDate":"2023-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139257162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The 2023 intensive care society cauldron: Five ways to tackle sustainability 2023 年重症监护社会大熔炉:解决可持续发展问题的五种方法
IF 2.7 Q3 CRITICAL CARE MEDICINE Pub Date : 2023-11-16 DOI: 10.1177/17511437231212072
Richard Kirkdale, Rasmus Knudsen, Emily Yeung, Catherine Anderson, Nina Hjelde, Peter G Brindley
{"title":"The 2023 intensive care society cauldron: Five ways to tackle sustainability","authors":"Richard Kirkdale, Rasmus Knudsen, Emily Yeung, Catherine Anderson, Nina Hjelde, Peter G Brindley","doi":"10.1177/17511437231212072","DOIUrl":"https://doi.org/10.1177/17511437231212072","url":null,"abstract":"","PeriodicalId":39161,"journal":{"name":"Journal of the Intensive Care Society","volume":"29 6","pages":""},"PeriodicalIF":2.7,"publicationDate":"2023-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139268844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Developing key performance indicators for adult critical care transfer services: Scoping review and Delphi technique. 制定成人重症监护转移服务的关键绩效指标:范围界定审查和德尔菲技术。
IF 2.7 Q3 CRITICAL CARE MEDICINE Pub Date : 2023-11-01 Epub Date: 2023-02-12 DOI: 10.1177/17511437231153049
Nick Haslam, Aurelien Giouse, Jonathon Dean, Mamoun Abu-Habsa, Simon J Finney

In 2021 NHS England commissioned regional Adult Critical Care Transfer Services. These services will replace a historically predominant ad hoc approach to adult critical care transfers nationally. It is anticipated that these new formal services will provide a system of robust regional & national governance previously acknowledged to be deficient. As part of this process, it is important that an agreed set of transfer service quality indicators are developed to drive equitable improvement in patient care. We used a Delphi technique to develop a set of key performance indicators through consensus for a recently established London critical care transfer service. We believe this may be the first-time key performance indicators have been developed for adult critical care transfer services using a consensus method. We hope services will consider tracking similar measures to enable benchmarking and drive improvements in patient care.

2021年,英国国家医疗服务体系(NHS England)委托区域成人重症监护转移服务。这些服务将取代历史上占主导地位的全国成人重症监护转移的临时方法。预计这些新的正式服务将提供一个强有力的区域和国家治理体系,此前人们认为这一体系存在缺陷。作为这一过程的一部分,重要的是制定一套商定的转移服务质量指标,以推动患者护理的公平改善。我们使用德尔菲技术,通过协商一致,为最近建立的伦敦重症监护转移服务制定了一套关键绩效指标。我们认为,这可能是首次使用共识方法为成人重症监护转移服务制定关键绩效指标。我们希望服务部门将考虑跟踪类似的措施,以实现基准测试并推动患者护理的改进。
{"title":"Developing key performance indicators for adult critical care transfer services: Scoping review and Delphi technique.","authors":"Nick Haslam,&nbsp;Aurelien Giouse,&nbsp;Jonathon Dean,&nbsp;Mamoun Abu-Habsa,&nbsp;Simon J Finney","doi":"10.1177/17511437231153049","DOIUrl":"10.1177/17511437231153049","url":null,"abstract":"<p><p>In 2021 NHS England commissioned regional Adult Critical Care Transfer Services. These services will replace a historically predominant ad hoc approach to adult critical care transfers nationally. It is anticipated that these new formal services will provide a system of robust regional & national governance previously acknowledged to be deficient. As part of this process, it is important that an agreed set of transfer service quality indicators are developed to drive equitable improvement in patient care. We used a Delphi technique to develop a set of key performance indicators through consensus for a recently established London critical care transfer service. We believe this may be the first-time key performance indicators have been developed for adult critical care transfer services using a consensus method. We hope services will consider tracking similar measures to enable benchmarking and drive improvements in patient care.</p>","PeriodicalId":39161,"journal":{"name":"Journal of the Intensive Care Society","volume":"24 4","pages":"438-441"},"PeriodicalIF":2.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572479/pdf/10.1177_17511437231153049.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41239525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the editor. 给编辑的信。
IF 2.7 Q3 CRITICAL CARE MEDICINE Pub Date : 2023-11-01 Epub Date: 2021-03-17 DOI: 10.1177/1751143721999947
Charissa J Zaga, Adam P Vogel, Sue Berney
{"title":"Letter to the editor.","authors":"Charissa J Zaga,&nbsp;Adam P Vogel,&nbsp;Sue Berney","doi":"10.1177/1751143721999947","DOIUrl":"https://doi.org/10.1177/1751143721999947","url":null,"abstract":"","PeriodicalId":39161,"journal":{"name":"Journal of the Intensive Care Society","volume":"24 3 Suppl","pages":"52"},"PeriodicalIF":2.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1751143721999947","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71491206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A resilient death: Gross oxymoron or realistic Utopia? 坚韧的死亡:粗俗的矛盾修辞法还是现实的乌托邦?
IF 2.7 Q3 CRITICAL CARE MEDICINE Pub Date : 2023-11-01 Epub Date: 2022-12-16 DOI: 10.1177/17511437221142252
Mark Zy Tan
{"title":"A resilient death: Gross oxymoron or realistic Utopia?","authors":"Mark Zy Tan","doi":"10.1177/17511437221142252","DOIUrl":"10.1177/17511437221142252","url":null,"abstract":"","PeriodicalId":39161,"journal":{"name":"Journal of the Intensive Care Society","volume":"1 1","pages":"63-64"},"PeriodicalIF":2.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621503/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45566209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A simple mortality prediction model for sepsis patients in intensive care. 重症监护中败血症患者的简单死亡率预测模型。
IF 2.7 Q3 CRITICAL CARE MEDICINE Pub Date : 2023-11-01 Epub Date: 2023-02-01 DOI: 10.1177/17511437221149572
Hazem Koozi, Adina Lidestam, Maria Lengquist, Patrik Johnsson, Attila Frigyesi
Background: Sepsis is common in the intensive care unit (ICU). Two of the ICU’s most widely used mortality prediction models are the Simplified Acute Physiology Score 3 (SAPS-3) and the Sequential Organ Failure Assessment (SOFA) score. We aimed to assess the mortality prediction performance of SAPS-3 and SOFA upon ICU admission for sepsis and find a simpler mortality prediction model for these patients to be used in clinical practice and when conducting studies. Methods: A retrospective study of adult patients fulfilling the Sepsis-3 criteria admitted to four general ICUs was performed. A simple prognostic model was created using backward stepwise multivariate logistic regression. The area under the curve (AUC) of SAPS-3, SOFA and the simple model was assessed. Results: One thousand nine hundred eighty four admissions were included. A simple six-parameter model consisting of age, immunosuppression, Glasgow Coma Scale, body temperature, C-reactive protein and bilirubin had an AUC of 0.72 (95% confidence interval (CI) 0.69–0.75) for 30-day mortality, which was non-inferior to SAPS-3 (AUC 0.75, 95% CI 0.72–0.77) (p = 0.071). SOFA had an AUC of 0.67 (95% CI 0.64–0.70) and was inferior to SAPS-3 (p < 0.001) and our simple model (p = 0.0019). Conclusion: SAPS-3 has a lower prognostic value in sepsis than in the general ICU population. SOFA performs less well than SAPS-3. Our simple six-parameter model predicts mortality just as well as SAPS-3 upon ICU admission for sepsis, allowing the design of simple studies and performance monitoring.
背景:脓毒症在重症监护室很常见。ICU最广泛使用的两个死亡率预测模型是简化急性生理学评分3(SAPS-3)和序贯器官衰竭评估(SOFA)评分。我们旨在评估SAPS-3和SOFA在败血症入住ICU时的死亡率预测性能,并为这些患者找到一个更简单的死亡率预测模型,用于临床实践和进行研究。方法:对四个普通ICU中符合Sepsis-3标准的成年患者进行回顾性研究。使用后向逐步多变量逻辑回归建立了一个简单的预后模型。评估SAPS-3、SOFA和简单模型的曲线下面积(AUC)。结果:包括一千九百八十四名住院患者。由年龄、免疫抑制、格拉斯哥昏迷量表、体温、C反应蛋白和胆红素组成的简单六参数模型30天死亡率的AUC为0.72(95%置信区间(CI)0.69-0.75),不劣于SAPS-3(AUC 0.75,95%CI 0.72-0.77)(p = 0.071)。SOFA的AUC为0.67(95%CI 0.64-0.70),低于SAPS-3(p p = 0.0019)。结论:SAPS-3对败血症的预后价值低于普通ICU人群。SOFA的性能不如SAPS-3。我们的简单六参数模型预测败血症入住ICU时的死亡率与SAPS-3一样好,允许设计简单的研究和性能监测。
{"title":"A simple mortality prediction model for sepsis patients in intensive care.","authors":"Hazem Koozi,&nbsp;Adina Lidestam,&nbsp;Maria Lengquist,&nbsp;Patrik Johnsson,&nbsp;Attila Frigyesi","doi":"10.1177/17511437221149572","DOIUrl":"https://doi.org/10.1177/17511437221149572","url":null,"abstract":"Background: Sepsis is common in the intensive care unit (ICU). Two of the ICU’s most widely used mortality prediction models are the Simplified Acute Physiology Score 3 (SAPS-3) and the Sequential Organ Failure Assessment (SOFA) score. We aimed to assess the mortality prediction performance of SAPS-3 and SOFA upon ICU admission for sepsis and find a simpler mortality prediction model for these patients to be used in clinical practice and when conducting studies. Methods: A retrospective study of adult patients fulfilling the Sepsis-3 criteria admitted to four general ICUs was performed. A simple prognostic model was created using backward stepwise multivariate logistic regression. The area under the curve (AUC) of SAPS-3, SOFA and the simple model was assessed. Results: One thousand nine hundred eighty four admissions were included. A simple six-parameter model consisting of age, immunosuppression, Glasgow Coma Scale, body temperature, C-reactive protein and bilirubin had an AUC of 0.72 (95% confidence interval (CI) 0.69–0.75) for 30-day mortality, which was non-inferior to SAPS-3 (AUC 0.75, 95% CI 0.72–0.77) (p = 0.071). SOFA had an AUC of 0.67 (95% CI 0.64–0.70) and was inferior to SAPS-3 (p < 0.001) and our simple model (p = 0.0019). Conclusion: SAPS-3 has a lower prognostic value in sepsis than in the general ICU population. SOFA performs less well than SAPS-3. Our simple six-parameter model predicts mortality just as well as SAPS-3 upon ICU admission for sepsis, allowing the design of simple studies and performance monitoring.","PeriodicalId":39161,"journal":{"name":"Journal of the Intensive Care Society","volume":"24 4","pages":"372-378"},"PeriodicalIF":2.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572475/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41239519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Bedside naso-jejunal placement is more difficult, but successful in patients with COVID-19 in critical care: A retrospective service evaluation of a dietitian-led service. 在重症监护中,新冠肺炎患者的床边鼻拭子放置更困难,但成功:一项由营养师主导的服务的回顾性服务评估。
IF 2.7 Q3 CRITICAL CARE MEDICINE Pub Date : 2023-11-01 Epub Date: 2023-02-11 DOI: 10.1177/17511437231153045
Mary E Phillips, Jessica Zekavica, Rajesh Kumar, Rajiv Lahiri, Justin Kirk-Bayley, Amish Patel, Adam E Frampton

The COVID-19 pandemic presented clinical and logistical challenges in the delivery of adequate nutrition in the critical care setting. The use of neuromuscular-blocking drugs, presence of maxilla-facial oedema, strict infection control procedures, and patients placed in a prone position complicated feeding tube placement. We audited the outcomes of dietitian-led naso-jejunal tube (NJT) insertions using the IRIS® (Kangaroo, USA) device, before and during the COVID-19 pandemic. NJT placement was successful in 78% of all cases (n = 50), and 87% of COVID-19 cases. Anaesthetic support was only required in COVID-19 patients (53%). NJT placement using IRIS was more difficult but achievable in patients with COVID-19.

新冠肺炎大流行在重症监护环境中提供足够营养方面带来了临床和后勤挑战。神经肌肉阻滞药物的使用,上颌骨面部水肿的存在,严格的感染控制程序,以及患者俯卧位,使喂食管的放置变得复杂。我们审计了在新冠肺炎大流行之前和期间,使用IRIS®(美国袋鼠)设备插入营养学家引导的鼻咽管(NJT)的结果。NJT置入成功率为78%(n = 50)和87%的新冠肺炎病例。仅新冠肺炎患者需要麻醉支持(53%)。在新冠肺炎患者中,使用IRIS的NJT放置更困难,但可以实现。
{"title":"Bedside naso-jejunal placement is more difficult, but successful in patients with COVID-19 in critical care: A retrospective service evaluation of a dietitian-led service.","authors":"Mary E Phillips,&nbsp;Jessica Zekavica,&nbsp;Rajesh Kumar,&nbsp;Rajiv Lahiri,&nbsp;Justin Kirk-Bayley,&nbsp;Amish Patel,&nbsp;Adam E Frampton","doi":"10.1177/17511437231153045","DOIUrl":"https://doi.org/10.1177/17511437231153045","url":null,"abstract":"<p><p>The COVID-19 pandemic presented clinical and logistical challenges in the delivery of adequate nutrition in the critical care setting. The use of neuromuscular-blocking drugs, presence of maxilla-facial oedema, strict infection control procedures, and patients placed in a prone position complicated feeding tube placement. We audited the outcomes of dietitian-led naso-jejunal tube (NJT) insertions using the IRIS<sup>®</sup> (Kangaroo, USA) device, before and during the COVID-19 pandemic. NJT placement was successful in 78% of all cases (<i>n</i> = 50), and 87% of COVID-19 cases. Anaesthetic support was only required in COVID-19 patients (53%). NJT placement using IRIS was more difficult but achievable in patients with COVID-19.</p>","PeriodicalId":39161,"journal":{"name":"Journal of the Intensive Care Society","volume":"24 4","pages":"435-437"},"PeriodicalIF":2.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922656/pdf/10.1177_17511437231153045.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41239522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is high sensitivity troponin, taken regardless of a clinical indication, associated with 1 year mortality in critical care patients? 无论临床指征如何服用的高敏肌钙蛋白是否与1 重症监护患者的年死亡率?
IF 2.7 Q3 CRITICAL CARE MEDICINE Pub Date : 2023-11-01 Epub Date: 2023-03-30 DOI: 10.1177/17511437231160078
Jonathan Hinton, Maclyn Augustine, Lavinia Gabara, Mark Mariathas, Rick Allan, Florina Borca, Zoe Nicholas, Neil Gillett, Chun Shing Kwok, Paul Cook, Michael Pw Grocott, Mamas Mamas, Nick Curzen

The aim of this study was to assess whether high sensitivity troponin (hs-cTnI) is associated with 1 year mortality in critical care (CC). One year mortality data were obtained from NHS Digital for a consecutive cohort of patients admitted to general CC unit (GCCU) and neuroscience CC unit (NCCU) who had hs-cTnI tests performed throughout their CC admission, regardless of whether the test was clinically indicated. Cox proportional hazards were used to estimate the risk of 1-year mortality. A landmark analysis was undertaken to assess whether any relationship at 1 year was driven by mortality within the first 30 days. A total of 1033 consecutive patients were included. At 1 year 254 (24.6%) patients had died. The admission log(10)hs-cTnI concentration in the entire cohort (HR 1.35 (95% CI 1.05-1.75) p = 0.009 with a bootstrap of 1000 samples) was independently associated with 1 year mortality. On landmark analysis the association with 1 year mortality was driven by 30 day mortality. These results indicate that admission hs-cTnI concentration is independently associated with 1 year mortality in CC and this relationship may be driven by differences in mortality at 30 days.

本研究的目的是评估高灵敏度肌钙蛋白(hs-cTnI)是否与1 重症监护的年死亡率(CC)。从NHS Digital获得了一年的死亡率数据,这些患者在普通CC单元(GCCU)和神经科学CC单元(NCCU)入院期间进行了hs-cTnI测试,无论该测试是否具有临床意义。Cox比例风险用于估计1年死亡率的风险。进行了一项里程碑式的分析,以评估在1 前30年的死亡率 天。共纳入1033名连续患者。在1 254年(24.6%)患者死亡。整个队列的入院对数(10)hs-cTnI浓度(HR 1.35(95%CI 1.05-1.75)p = 0.009,具有1000个样本的引导)与1 年死亡率。关于地标分析与1的关联 年死亡率由30 日死亡率。这些结果表明,入院hs-cTnI浓度与1 CC的年死亡率和这种关系可能是由30岁时死亡率的差异驱动的 天。
{"title":"Is high sensitivity troponin, taken regardless of a clinical indication, associated with 1 year mortality in critical care patients?","authors":"Jonathan Hinton,&nbsp;Maclyn Augustine,&nbsp;Lavinia Gabara,&nbsp;Mark Mariathas,&nbsp;Rick Allan,&nbsp;Florina Borca,&nbsp;Zoe Nicholas,&nbsp;Neil Gillett,&nbsp;Chun Shing Kwok,&nbsp;Paul Cook,&nbsp;Michael Pw Grocott,&nbsp;Mamas Mamas,&nbsp;Nick Curzen","doi":"10.1177/17511437231160078","DOIUrl":"https://doi.org/10.1177/17511437231160078","url":null,"abstract":"<p><p>The aim of this study was to assess whether high sensitivity troponin (hs-cTnI) is associated with 1 year mortality in critical care (CC). One year mortality data were obtained from NHS Digital for a consecutive cohort of patients admitted to general CC unit (GCCU) and neuroscience CC unit (NCCU) who had hs-cTnI tests performed throughout their CC admission, regardless of whether the test was clinically indicated. Cox proportional hazards were used to estimate the risk of 1-year mortality. A landmark analysis was undertaken to assess whether any relationship at 1 year was driven by mortality within the first 30 days. A total of 1033 consecutive patients were included. At 1 year 254 (24.6%) patients had died. The admission log(10)hs-cTnI concentration in the entire cohort (HR 1.35 (95% CI 1.05-1.75) <i>p</i> = 0.009 with a bootstrap of 1000 samples) was independently associated with 1 year mortality. On landmark analysis the association with 1 year mortality was driven by 30 day mortality. These results indicate that admission hs-cTnI concentration is independently associated with 1 year mortality in CC and this relationship may be driven by differences in mortality at 30 days.</p>","PeriodicalId":39161,"journal":{"name":"Journal of the Intensive Care Society","volume":"24 4","pages":"392-398"},"PeriodicalIF":2.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572482/pdf/10.1177_17511437231160078.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41239605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
biomArker-guided Duration of Antibiotic treatment in hospitalised Patients with suspecTed Sepsis (ADAPT-Sepsis): A protocol for a multicentre randomised controlled trial. 生物标志物指导的疑似脓毒症住院患者抗生素治疗持续时间:一项多中心随机对照试验的方案。
IF 2.7 Q3 CRITICAL CARE MEDICINE Pub Date : 2023-11-01 Epub Date: 2023-04-25 DOI: 10.1177/17511437231169193
Paul Dark, Gavin D Perkins, Ronan McMullan, Danny McAuley, Anthony C Gordon, Jonathan Clayton, Dipesh Mistry, Keith Young, Scott Regan, Nicola McGowan, Matt Stevenson, Simon Gates, Gordon L Carlson, Tim Walsh, Nazir I Lone, Paul R Mouncey, Mervyn Singer, Peter Wilson, Tim Felton, Kay Marshall, Anower M Hossain, Ranjit Lall

Aim: To describe the protocol for a multi-centre randomised controlled trial to determine whether treatment protocols monitoring daily CRP (C-reactive protein) or PCT (procalcitonin) safely allow a reduction in duration of antibiotic therapy in hospitalised adult patients with sepsis.

Design: Multicentre three-arm randomised controlled trial.

Setting: UK NHS hospitals.

Target population: Hospitalised critically ill adults who have been commenced on intravenous antibiotics for sepsis.

Health technology: Three protocols for guiding antibiotic discontinuation will be compared: (a) standard care; (b) standard care + daily CRP monitoring; (c) standard care + daily PCT monitoring. Standard care will be based on routine sepsis management and antibiotic stewardship. Measurement of outcomes and costs. Outcomes will be assessed to 28 days. The primary outcomes are total duration of antibiotics and safety outcome of all-cause mortality. Secondary outcomes include: escalation of care/re-admission; infection re-lapse/recurrence; antibiotic dose; length and level of critical care stay and length of hospital stay. Ninety-day all-cause mortality rates will also be collected. An assessment of cost effectiveness will be performed.

Conclusion: In the setting of routine NHS care, if this trial finds that a treatment protocol based on monitoring CRP or PCT safely allows a reduction in duration of antibiotic therapy, and is cost effective, then this has the potential to change clinical practice for critically ill patients with sepsis. Moreover, if a biomarker-guided protocol is not found to be effective, then it will be important to avoid its use in sepsis and prevent ineffective technology becoming widely adopted in clinical practice.

目的:描述一项多中心随机对照试验的方案,以确定监测每日CRP(C反应蛋白)或PCT(降钙素原)的治疗方案是否可以安全地缩短败血症住院成年患者的抗生素治疗时间。设计:多中心三组随机对照试验。背景:英国国家医疗服务体系医院。目标人群:已开始静脉注射抗生素治疗败血症的住院危重成年人。卫生技术:将比较指导抗生素停用的三个方案:(a)标准护理;(b) 标准护理+每日CRP监测;(c) 标准护理+每日PCT监测。标准护理将以常规败血症管理和抗生素管理为基础。成果和成本的衡量。结果将评估为28 天。主要结果是抗生素的总持续时间和全因死亡率的安全性结果。次要结果包括:护理升级/再次入院;感染复发;抗生素剂量;重症监护住院时间和水平以及住院时间。还将收集90天全因死亡率。将对成本效益进行评估。结论:在常规NHS护理的环境中,如果该试验发现基于监测CRP或PCT的治疗方案可以安全地缩短抗生素治疗的持续时间,并且具有成本效益,那么这有可能改变败血症危重患者的临床实践。此外,如果生物标志物引导的方案没有被发现是有效的,那么重要的是避免其在败血症中的使用,并防止无效技术在临床实践中被广泛采用。
{"title":"biomArker-guided Duration of Antibiotic treatment in hospitalised Patients with suspecTed Sepsis (ADAPT-Sepsis): A protocol for a multicentre randomised controlled trial.","authors":"Paul Dark, Gavin D Perkins, Ronan McMullan, Danny McAuley, Anthony C Gordon, Jonathan Clayton, Dipesh Mistry, Keith Young, Scott Regan, Nicola McGowan, Matt Stevenson, Simon Gates, Gordon L Carlson, Tim Walsh, Nazir I Lone, Paul R Mouncey, Mervyn Singer, Peter Wilson, Tim Felton, Kay Marshall, Anower M Hossain, Ranjit Lall","doi":"10.1177/17511437231169193","DOIUrl":"10.1177/17511437231169193","url":null,"abstract":"<p><strong>Aim: </strong>To describe the protocol for a multi-centre randomised controlled trial to determine whether treatment protocols monitoring daily CRP (C-reactive protein) or PCT (procalcitonin) safely allow a reduction in duration of antibiotic therapy in hospitalised adult patients with sepsis.</p><p><strong>Design: </strong>Multicentre three-arm randomised controlled trial.</p><p><strong>Setting: </strong>UK NHS hospitals.</p><p><strong>Target population: </strong>Hospitalised critically ill adults who have been commenced on intravenous antibiotics for sepsis.</p><p><strong>Health technology: </strong>Three protocols for guiding antibiotic discontinuation will be compared: (a) standard care; (b) standard care + daily CRP monitoring; (c) standard care + daily PCT monitoring. Standard care will be based on routine sepsis management and antibiotic stewardship. Measurement of outcomes and costs. Outcomes will be assessed to 28 days. The primary outcomes are total duration of antibiotics and safety outcome of all-cause mortality. Secondary outcomes include: escalation of care/re-admission; infection re-lapse/recurrence; antibiotic dose; length and level of critical care stay and length of hospital stay. Ninety-day all-cause mortality rates will also be collected. An assessment of cost effectiveness will be performed.</p><p><strong>Conclusion: </strong>In the setting of routine NHS care, if this trial finds that a treatment protocol based on monitoring CRP or PCT safely allows a reduction in duration of antibiotic therapy, and is cost effective, then this has the potential to change clinical practice for critically ill patients with sepsis. Moreover, if a biomarker-guided protocol is not found to be effective, then it will be important to avoid its use in sepsis and prevent ineffective technology becoming widely adopted in clinical practice.</p>","PeriodicalId":39161,"journal":{"name":"Journal of the Intensive Care Society","volume":"24 4","pages":"427-434"},"PeriodicalIF":2.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572477/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41239523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of acute aortic dissection in critical care. 重症监护中急性主动脉夹层的处理。
IF 2.7 Q3 CRITICAL CARE MEDICINE Pub Date : 2023-11-01 Epub Date: 2023-03-29 DOI: 10.1177/17511437231162219
Luke Flower, Joseph E Arrowsmith, Jeremy Bewley, Samantha Cook, Graham Cooper, Jake Flower, Renata Greco, Syed Sadeque, Pradeep R Madhivathanan

Aortic dissections are associated with significant mortality and morbidity, with rapid treatment paramount. They are caused by a tear in the intimal lining of the aorta that extends into the media of the wall. Blood flow through this tear leads to the formation of a false passage bordered by the inner and outer layers of the media. Their diagnosis is challenging, with most deaths caused by aortic dissection diagnosed at post-mortem. Aortic dissections are classified by location and chronicity, with management strategies depending on the nature of the dissection. The Stanford method splits aortic dissections into type A and B, with type A dissections involving the ascending aorta. De Bakey classifies dissections into I, II or III depending on their origin and involvement and degree of extension. The key to diagnosis is early suspicion, appropriate imaging and rapid initiation of treatment. Treatment focuses on initial resuscitation, transfer (if possible and required) to a suitable specialist centre, strict blood pressure and heart rate control and potentially surgical intervention depending on the type and complexity of the dissection. Effective post-operative care is extremely important, with awareness of potential post-operative complications and a multi-disciplinary rehabilitation approach required. In this review article we will discuss the aetiology and classifications of aortic dissection, their diagnosis and treatment principles relevant to critical care. Critical care clinicians play a key part in all these steps, from diagnosis through to post-operative care, and thus a thorough understanding is vital.

主动脉夹层与显著的死亡率和发病率相关,快速治疗至关重要。它们是由主动脉内膜撕裂引起的,主动脉内膜延伸到壁的中间层。通过这种撕裂的血液流动导致形成一个由介质的内层和外层界定的假通道。他们的诊断具有挑战性,大多数死亡是在死后诊断为主动脉夹层。主动脉夹层按位置和时间分类,管理策略取决于夹层的性质。斯坦福方法将主动脉夹层分为A型和B型,其中A型夹层涉及升主动脉。De Bakey根据解剖的起源、涉及程度和扩展程度将解剖分为I、II或III。诊断的关键是早期怀疑、适当的成像和快速开始治疗。治疗重点是初步复苏、转移(如果可能和需要)到合适的专科中心、严格控制血压和心率,以及根据解剖的类型和复杂性进行潜在的手术干预。有效的术后护理极其重要,需要意识到潜在的术后并发症,并采取多学科的康复方法。在这篇综述文章中,我们将讨论主动脉夹层的病因和分类,以及与重症监护相关的诊断和治疗原则。从诊断到术后护理,重症监护临床医生在所有这些步骤中都发挥着关键作用,因此彻底了解至关重要。
{"title":"Management of acute aortic dissection in critical care.","authors":"Luke Flower,&nbsp;Joseph E Arrowsmith,&nbsp;Jeremy Bewley,&nbsp;Samantha Cook,&nbsp;Graham Cooper,&nbsp;Jake Flower,&nbsp;Renata Greco,&nbsp;Syed Sadeque,&nbsp;Pradeep R Madhivathanan","doi":"10.1177/17511437231162219","DOIUrl":"10.1177/17511437231162219","url":null,"abstract":"<p><p>Aortic dissections are associated with significant mortality and morbidity, with rapid treatment paramount. They are caused by a tear in the intimal lining of the aorta that extends into the media of the wall. Blood flow through this tear leads to the formation of a false passage bordered by the inner and outer layers of the media. Their diagnosis is challenging, with most deaths caused by aortic dissection diagnosed at post-mortem. Aortic dissections are classified by location and chronicity, with management strategies depending on the nature of the dissection. The Stanford method splits aortic dissections into type A and B, with type A dissections involving the ascending aorta. De Bakey classifies dissections into I, II or III depending on their origin and involvement and degree of extension. The key to diagnosis is early suspicion, appropriate imaging and rapid initiation of treatment. Treatment focuses on initial resuscitation, transfer (if possible and required) to a suitable specialist centre, strict blood pressure and heart rate control and potentially surgical intervention depending on the type and complexity of the dissection. Effective post-operative care is extremely important, with awareness of potential post-operative complications and a multi-disciplinary rehabilitation approach required. In this review article we will discuss the aetiology and classifications of aortic dissection, their diagnosis and treatment principles relevant to critical care. Critical care clinicians play a key part in all these steps, from diagnosis through to post-operative care, and thus a thorough understanding is vital.</p>","PeriodicalId":39161,"journal":{"name":"Journal of the Intensive Care Society","volume":"24 4","pages":"409-418"},"PeriodicalIF":2.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572474/pdf/10.1177_17511437231162219.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41239606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the Intensive Care Society
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1